Overcoming Bottlenecks: Biopharma’s Big Challenge Is Execution

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 26 Oct, 18:22 UTC

The biggest challenge facing the biopharma industry isn’t scientific innovation. It’s manufacturing execution. Closing this gap is one of the greatest opportunities biopharma has today to enhance resilience and unlock the full value of its science. The post Overcoming Bottlenecks: Biopharma’s Big…

science

Sources

• T2Overcoming Bottlenecks: Biopharma’s Big Challenge Is ExecutionFierce Biotech / Fierce Healthcare / MedCity / GEN26 Oct, 18:22